Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart. (Q54463866)

30 May 2018

title

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart. (English)

1 reference

30 May 2018

author

Derek Hausenloy

1

1 reference

30 May 2018

Derek M. Yellon

4

object named as

Derek M Yellon

1 reference

30 May 2018

Mihaela M Mocanu

3

object named as

Mihaela M Mocanu

1 reference

30 May 2018

Abigail M Wynne

2

object named as

Abigail M Wynne

1 reference

30 May 2018

publication date

21 December 2012

1 reference

30 May 2018

Journal of Cardiovascular Pharmacology and Therapeutics

published in

1 reference

30 May 2018

volume

18

1 reference

30 May 2018

page(s)

263-269

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Protein kinase B in the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Protection afforded by preconditioning to the diabetic heart against ischaemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Role of calcitonin gene-related peptide in ischaemic preconditioning in diabetic rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Preconditioning the diabetic heart: the importance of Akt phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Failure to precondition pathological human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Isoflurane-induced preconditioning is attenuated by diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Microvascular protection induced by late preconditioning was abolished in STZ-induced acute diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Impairment of myocardial protection in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a kappa-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Preconditioning the diabetic human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Ischemic postconditioning in pigs: no causal role for RISK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248412468945

21 January 2018

Identifiers

DOI

10.1177/1074248412468945

1 reference

30 May 2018

PubMed ID

23263382

1 reference

30 May 2018